Abstract:Precision medicine relies on high-accuracy individual-level genotype data. However, the whole-genome sequencing (WGS) is currently not suitable for studies with very large sample sizes due to budget constraints. It is particularly important to construct highly accurate haplotype reference panel for genotype imputation. In this study, we selected 9,950 individuals from the China Kadoorie Biobank (CKB) cohort and 50 Chinese samples from the 1000 Genome Project (1KGP) for medium-depth WGS to construct a CKB reference panel. The results of imputing microarray datasets showed that the CKB panel outperformed the extended high coverage 1KGP, TOPMed, ChinaMAP, and NuyWa panels in terms of both the number of well-imputed variants and imputation accuracy. In addition, we have completed the imputation of over 100,000 CKB microarray data with the CKB panel, and the after-imputed genotype data is the hitherto largest whole genome data of the Chinese population. Finally, we developed an online server for offering free genotype imputation service based on the CKB reference panel (<https://db.cngb.org/imputation/>). We believe that the constructed CKB reference panel is of great value for imputing microarray or low-depth genotype data of Chinese population. The imputation-completed 100,000 microarray data are fundamental resources of population genetic studies for complex traits and diseases in the Chinese population. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants (2016YFC0900500) from the National Key R&D Program of China, National Natural Science Foundation of China (32000398, 82192901, 82192904, 82192900), the China National GeneBank, Guangdong Provincial Key Laboratory of Genome Read and Write (2017B030301011) and Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (2017B090904014). The CKB baseline survey and the first re-survey were supported by a grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term follow-up is supported by grants from the UK Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z), National Natural Science Foundation of China (81390540, 91846303, 81941018), and Chinese Ministry of Science and Technology (2011BAI09B01). The funders had no role in the study design, data collection, data analysis and interpretation, writing of the report, or the decision to submit the article for publication. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee/IRB of Beijing Genomics Institute(BGI) gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The CKB reference panel and the after-imputed over 100,000 CKB microarray data have been deposited into CNGB Sequence Archive (CNSA) of China National GeneBank DataBase (CNGBdb) with accession number CNP0003405. All genotype data are shared with controlled management.All data produced are available online at <https://db.cngb.org/cnsa/>

Quartet DNA reference materials and datasets for comprehensively evaluating germline variants calling performance

Quartet DNA reference materials and datasets for comprehensively evaluating germline variant calling performance

Quartet RNA Reference Materials and Ratio-Based Reference Datasets for Reliable Transcriptomic Profiling

Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profiling

Haplotype-resolved assemblies and variant benchmark of a Chinese Quartet

Multi-omics data integration using ratio-based quantitative profiling with Quartet reference materials

A Real-World Multi-Center RNA-seq Benchmarking Study Using the Quartet and MAQC Reference Materials

Ratio-based quantitative multiomics profiling using universal reference materials empowers data integration

Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

Toward Best Practice in Identifying Subtle Differential Expression with RNA-seq: A Real-World Multi-Center Benchmarking Study Using Quartet and MAQC Reference Materials

A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency

A High-resolution Haplotype-resolved Reference Panel Constructed from the China Kadoorie Biobank Study

Germline And Somatic Variant Identification Using Bgiseq-500 And Hiseq X Ten Whole Genome Sequencing

Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project

Automated Identification of Germline de novo Mutations in Family Trios: A Consensus-Based Informatic Approach

Curated variation benchmarks for challenging medically relevant autosomal genes

A robust benchmark for detecting low-frequency variants in the HG002 Genome In A Bottle NIST reference material.

Quality Control of Next-generation Sequencing-based in Vitro Diagnostic Test for Onco-relevant Mutations Using Multiplex Reference Materials in Plasma

Optimizing Accuracy and Efficiency in Analyzing Non-UMI Liquid Biopsy Datasets Using the Sentieon ctDNA Pipeline

Whole Genome and Exome Sequencing Reference Datasets from a Multi-Center and Cross-Platform Benchmark Study